Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 5/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | PTPN7 | P35236 | 3/20 | 0.38 |
| ▸ | HMGCR | P04035 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17260760 | 1.00 | PAOX (0.50) | PAOXALDH1A1TSHRACHEPTPN7 | |
| SCHEMBL10370310 | 1.00 | PAOX (0.50) | PAOXALDH1A1TSHRACHEPTPN7 | |
| SCHEMBL7779358 | 0.98 | — | — | |
| SCHEMBL9551989 | 0.92 | TSHR (0.50) | ALDH1A1TSHRPTPN7HMGCRHSD17B10 | |
| SCHEMBL329262 | 0.90 | — | — | |
| Ethylene SCHEMBL8561240 | 0.86 | ALDH1A1 (0.41) | PAOXALDH1A1TSHRACHELMNA | |
| Water SCHEMBL17727821 | 0.79 | — | — | |
| SCHEMBL304991 | 0.79 | — | — | |
| SCHEMBL16723870 | 0.79 | PAOX (0.72) | PAOXALDH1A1TSHRACHEHSD17B10 | |
| SCHEMBL3626142 | 0.79 | PAOX (0.72) | PAOXALDH1A1TSHRACHEHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0402063-B1 | Alpha-(omega-cyanoalkanoyl)-gamma-butyrolactone and method for producing the same | UBE INDUSTRIES (JP) | 1994-09-21 | — | — | EP | claimed |
| US-20210246106-A1 | ACETYL-COA CARBOXYLASE MODULATORS | MONSANTO TECHNOLOGY LLC (US) | 2021-08-12 | — | — | US | disclosed |
| US-10995070-B2 | Acetyl-CoA carboxylase modulators | MONSANTO TECHNOLOGY LLC (US) | 2021-05-04 | — | — | US | disclosed |
| US-20190135757-A1 | ACETYL-COA CARBOXYLASE MODULATORS | MONSANTO TECHNOLOGY LLC (US) | 2019-05-09 | — | — | US | disclosed |
| US-10207995-B2 | Acetyl CoA carboxylase modulators | MONSANTO TECHNOLOGY LLC (US) | 2019-02-19 | — | — | US | disclosed |
| US-20160145212-A1 | ACETYL-COA CARBOXYLASE MODULATORS | MONSANTO TECHNOLOGY LLC (US) | 2016-05-26 | — | — | US | disclosed |
| WO-2014201327-A1 | ACETYL-COA CARBOXYLASE MODULATORS | MONSANTO TECHNOLOGY LLC (US) | 2014-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210246106-A1 | ACETYL-COA CARBOXYLASE MODULATORS | ACACA, ACACB, ACAT2 | PAOX 96/4885ALDH1A1 1039/4885TSHR 4654/4885 |
| US-20160145212-A1 | ACETYL-COA CARBOXYLASE MODULATORS | ACACA, ACACB, ACAT2 | PAOX 96/4885ALDH1A1 1039/4885TSHR 4654/4885 |
| US-10207995-B2 | Acetyl CoA carboxylase modulators | ACACA, ACACB, ACAT2 | PAOX 98/4885ALDH1A1 1076/4885TSHR 4698/4885 |
| US-20190135757-A1 | ACETYL-COA CARBOXYLASE MODULATORS | ACACA, ACACB, ACAT2 | PAOX 96/4885ALDH1A1 1039/4885TSHR 4654/4885 |
| US-10995070-B2 | Acetyl-CoA carboxylase modulators | ACACA, ACACB, ACAT2 | PAOX 96/4885ALDH1A1 1039/4885TSHR 4654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.